IAD Index of Academic Documents
  • Home Page
  • About
    • About Izmir Academy Association
    • About IAD Index
    • IAD Team
    • IAD Logos and Links
    • Policies
    • Contact
  • Submit A Journal
  • Submit A Conference
  • Submit Paper/Book
    • Submit a Preprint
    • Submit a Book
  • Contact
  • Turkish Journal of Chemistry
  • Volume:36 Issue:3
  • Synthesis, anti-inflammatory, antiplatelet and in silico evaluations of (E)-3-(3-(2,3-dihydro-3-meth...

Synthesis, anti-inflammatory, antiplatelet and in silico evaluations of (E)-3-(3-(2,3-dihydro-3-methyl-2-oxo3H -benzoxazole-6-yl)-1-phenyl-1H -pyrazole4-yl)acrylamides

Authors : Sultan BAYTAŞ, Nilüfer Nermin Turan DURAL, Yeşim ÖZKAN
Pages : 367-382
Doi:10.3906/sag-1302-132
View : 18 | Download : 8
Publication Date : 0000-00-00
Article Type : Research Paper
Abstract :A series of insert ignore into journalissuearticles values(E);-3-insert ignore into journalissuearticles values(3-insert ignore into journalissuearticles values(2,3-dihydro-3-methyl-2-oxo-3H-benzoxazole- 6-yl);-1-phenyl-1H-pyrazole-4-yl);acry- lamides insert ignore into journalissuearticles values(7a--k); were synthesized and evaluated for their in vitro inhibitory activities on COX-1 and COX-2 isoforms using a human whole blood assay as well as their antiplatelet profile against human platelet aggregation using arachidonic acid as agonists. Among the synthesized derivatives 7a--k, especially compound 7g exhibited dual anti-inflammatory and antiplatelet activity with selective COX-2 inhibition.
Keywords : Anti inflammatory activity, antiplatelet activity, pyrazoles, COX, TXA2 synthetase

ORIGINAL ARTICLE URL
VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.


Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2025